Incyte
INCY
#1110
Rank
S$26.08 B
Marketcap
S$132.86
Share price
2.05%
Change (1 day)
32.48%
Change (1 year)

Incyte (INCY) - Cash on Hand

Cash on Hand as of September 2025 : S$3.79 Billion

According to Incyte's latest financial reports the company has S$3.79 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Incyte - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$2.93 B-39.25%
2023-12-31S$4.82 B11.2%
2022-12-31S$4.34 B36.78%
2021-12-31S$3.17 B33.21%
2020-12-31S$2.38 B-16.52%
2019-12-31S$2.85 B45.29%
2018-12-31S$1.96 B25.61%
2017-12-31S$1.56 B33.69%
2016-12-31S$1.17 B16.88%
2015-12-31S$1.00 B26.23%
2014-12-31S$0.79 B22.99%
2013-12-31S$0.64 B130.87%
2012-12-31S$0.27 B-22.3%
2011-12-31S$0.35 B-34.2%
2010-12-31S$0.54 B-17.27%
2009-12-31S$0.66 B133.2%
2008-12-31S$0.28 B-23.25%
2007-12-31S$0.36 B-24.46%
2006-12-31S$0.48 B-14.95%
2005-12-31S$0.57 B-25.05%
2004-12-31S$0.76 B53.53%
2003-12-31S$0.49 B-32.94%
2002-12-31S$0.74 B-20.83%
2001-12-31S$0.94 B-6.82%
2000-12-31S$1.00 B805.84%
1999-12-31S$0.11 B-39.33%
1998-12-31S$0.18 B95.85%
1997-12-31S$93.74 M781.34%
1996-12-31S$10.63 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
S$12.23 B 222.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.87 B-76.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$12.84 B 238.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$19.41 B 411.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.49 B-87.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.31 B-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$12.63 B 232.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
S$0.10 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S$76.47 M-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA